| Today's Open | $74.30 |
|---|---|
| Previous Close | $74.67 |
| Daily Range | $73.25 - $87.50 |
| 52-Week Range | $42.47 - $87.50 |
| Market Cap | $25.8B |
| P/E Ratio | -173.65 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 10,383,614 |
| Average Daily Volume | 1,237,956 |
| Current FY EPS | $2.96 |
Sector
Healthcare
Industry
Drugs
Valeant Pharmaceuticals International (VRX) Description
A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/
News & Commentary
Why Valeant Pharmaceuticals Shares Spiked
Valeant may go shopping this weekend, and investors seem to like that idea.Everyone Wins From This Acquisition
Actavis buys Warner Chilcott rather than get acquired itself and investors win.VRX's Top Competitors
(13.12%)
(-0.45%)
(0.73%)
(0.61%)